← FDA DRUG APPROVALS

FDA ANDA · ANDA062944

CLINDAMYCIN PHOSPHATE

Sponsor: BOCA PHARMA LLC

APPLICATION
ANDA062944
TYPE
ANDA
ORIGINAL APPROVAL
1989-01-11
LATEST ACTION
1999-03-23
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

CLINDAMYCIN PHOSPHATEDiscontinued
CLINDAMYCIN PHOSPHATE EQ 1% BASE · SOLUTION · TOPICAL

Approval history

1999-03-23Manufacturing (CMC) · Supplement 8AP
1996-05-31Manufacturing (CMC) · Supplement 6AP
1996-05-08Manufacturing (CMC) · Supplement 7AP
1994-04-15Manufacturing (CMC) · Supplement 3AP
1994-02-08Manufacturing (CMC) · Supplement 2AP
1993-03-24Labeling · Supplement 1AP
1989-01-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →